CITADEL ADVISORS LLC 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
CITADEL ADVISORS LLC | 511,316 1.700% |
-823,557 (-61.70%) |
Filing |
| 2022-10-17 4:08 pm Purchase |
2022-10-07 | 13G | Relmada Therapeutics, Inc. RLMD |
CITADEL ADVISORS LLC | 1,334,873 4.400% |
1,334,873 (New Position) |
Filing |